Fertility in male patients with Hodgkin's disease - Results from the German Hodgkin Lymphoma Study Group (GHSG).

被引：0
|
作者：
Sieniawski, M [1 ]
Josting, A [1 ]
Breuer, K [1 ]
Diehl, V [1 ]
Engert, A [1 ]
机构：
[1] Univ Hosp Cologne, Clin Intermal Med 1, Cologne, Germany
来源：
BLOOD | 2004年 / 104卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1315
引用
收藏
页码：370A / 370A
页数：1
相关论文
共 50 条
  • [41] Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma - Results of a large multicenter study of the German Hodgkin lymphoma study group (GHSG).
    Josting, A
    Rudolph, C
    Mapara, M
    Glossmann, JP
    Sieber, M
    Kirchner, HH
    Doerken, B
    Hossfeld, DK
    Kisro, J
    Metzner, B
    Berdel, WE
    Diehl, V
    Engert, A
    BLOOD, 2003, 102 (11) : 402A - 402A
  • [42] Hodgkin's lymphoma in elderly patients:: A comprehensive retrospective analysis from the German Hodgkin's Study Group
    Engert, A
    Ballova, V
    Haverkamp, H
    Pfistner, B
    Josting, A
    Dühmke, E
    Müller-Hermelink, K
    Diehl, V
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) : 5052 - 5060
  • [43] A new BACOPP schedule is feasible and effective in elderly Hodgkin's lymphoma patients -: Interim results of a multicenter phase-II trial of the German Hodgkin Study Group (GHSG)
    Nogová, L
    Sieniawski, M
    Nisters-Backes, H
    Jennissen, V
    Klimm, B
    Wielckens, K
    Diehl, V
    Josting, A
    ANNALS OF ONCOLOGY, 2005, 16 : 195 - 195
  • [44] Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma -: Results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG).
    Josting, A
    Rudolph, C
    Mapara, M
    Glossmann, JP
    Sieber, M
    Kirchner, HH
    Dörken, B
    Hossfeld, DK
    Kisro, J
    Metzner, B
    Berdel, WE
    Diehl, V
    Engert, A
    BLOOD, 2004, 104 (11) : 92A - 92A
  • [45] Comparison of patients (Pts) characteristic and treatment outcomes in lymphocyte-predominant (LPHD) and classical Hodgkin's disease (cHD): A report from the German Hodgkin Lymphoma Study Group (GHSG).
    Nogova, L
    Reineke, T
    Josting, A
    Behringer, K
    Pfistner, B
    Diehl, V
    Engert, A
    BLOOD, 2004, 104 (11) : 368A - 369A
  • [46] The radiotherapy reference panel -: experiences and results of the German Hodgkin Study Group (GHSG)
    Eich, HT
    Müller, RP
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2005, 75 : 98 - 105
  • [47] Outcomes of patients with the third or higher relapsed classical Hodgkin lymphoma: results from the German Hodgkin Study Group
    Broeckelmann, P. J.
    Mueller, H.
    Kuecueksarioglan, E.
    Kaskel, P.
    Metterlein, V.
    Giezek, H.
    Balakumaran, A.
    Raut, M. K.
    Engert, A.
    von Tresckow, B.
    ANNALS OF ONCOLOGY, 2019, 30 (03) : 490 - 491
  • [48] Longitudinal assessment of the quality of life (QoL) in patients with Hodgkin's disease treated in the HD 8 trial of the German Hodgkin Study Group (GHSG).
    Ruffer, U
    Flechtner, H
    Hammerstein, O
    Sieber, M
    Diehl, V
    BLOOD, 1997, 90 (10) : 3950 - 3950
  • [49] Leucopenia during treatment is a good prognostic risk factor for patients undergoing chemotherapy for Hodgkin's lymphoma: An analysis of the German Hodgkin study group (GHSG).
    Klimm, B
    Reineke, T
    Haverkamp, H
    Eich, HT
    Behringer, K
    Josting, A
    Pfistner, B
    Diehl, V
    Engert, A
    BLOOD, 2005, 106 (11) : 750A - 751A
  • [50] Mortality during treatment of patients with advanced Hodgkin's lymphoma undergoing dose escalated BEACOPP chemotherapy: An analysis of the German Hodgkin study group (GHSG).
    Fuchs, M
    Franklin, J
    Klimm, B
    Josting, A
    Pfistner, B
    Engert, A
    Diehl, V
    BLOOD, 2005, 106 (11) : 749A - 749A
12345